BSE · AMERISE
AMERISE BIOSCIENCES LIMITED
Historical price visualisation is temporarily undergoing corporate data-licensing maintenance. Full interactive price and chart data will return following our upcoming authorized NSE/BSE data-feed deployment. Derived metrics (valuation ratios, market-cap rank), company financials, shareholding, corporate actions, and mutual-fund holdings remain available.
Market cap rank
#4,765
of 5,004 stocks
🏆 New peak
▲ 191W
Peak #4,765 · 01 Oct 2026
AMERISE BIOSCIENCES LIMITED, a microcap Healthcare business, is growing revenue rapidly, has a subdued return on equity, and has a widely-held ownership base, with promoters at just 0%.
Market Cap
5.35 Cr
P/E Ratio
—
P/B Ratio
0.99
ROE
0.30%
ROCE
0.38%
Dividend Yield
—
52W High
—
52W Low
—
Quarterly financials
| Metric | Q1 2026-27 | Q4 2025-26 | Q3 2025-26 | Q2 2025-26 |
|---|---|---|---|---|
| Revenue | Rs 0 | 7.92 L | Rs 0 | Rs 0 |
| Net Profit | -8.15 L | 6.13 L | Rs 97,000 | -4.23 L |
| EPS | 0.01 | 0.01 | 0.00 | 0.01 |
| Operating Profit | -8.15 L | 6.13 L | Rs 97,000 | -4.23 L |
Shareholding pattern
Promoter
0.00%
Public
100.00%
PUBLIC BREAKDOWN
Individuals
70.32%
Mutual fund holdings
Mutual fund holdings data for this stock hasn't been ingested yet — check back soon.
Recent corporate actions
No corporate actions on record for this stock.
Need this data in your app?
Full price history, technical indicators, and every field above via one REST API call.